Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Public ClinicalTrials.gov record NCT06651281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis
Study identification
- NCT ID
- NCT06651281
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 1,380 participants
Conditions and interventions
Conditions
Interventions
- Placebo to tulisokibart Drug
- Tulisokibart Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 24, 2024
- Primary completion
- Dec 16, 2037
- Completion
- Dec 16, 2037
- Last update posted
- Dec 25, 2025
2024 – 2037
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connecticut Clinical Research Institute ( Site 0297) | Bristol | Connecticut | 06010 | Recruiting |
| St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287) | Ypsilanti | Michigan | 48197 | Recruiting |
| BVL Research - Kansas ( Site 0292) | Liberty | Missouri | 64068 | Recruiting |
| New York Gastroenterology Associates ( Site 0253) | New York | New York | 10075 | Recruiting |
| GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290) | Garland | Texas | 75044 | Recruiting |
| GI Alliance - Lubbock ( Site 0288) | Lubbock | Texas | 79410 | Recruiting |
| Caprock Gastro Research ( Site 0293) | Lubbock | Texas | 79424 | Recruiting |
| Southern Star Research Institute ( Site 0299) | San Antonio | Texas | 78229 | Recruiting |
| GI Alliance - Southlake ( Site 0298) | Southlake | Texas | 76092-9167 | Recruiting |
| Tyler Research Institute ( Site 0294) | Tyler | Texas | 75701 | Recruiting |
| University of Virginia Health System ( Site 0291) | Charlottesville | Virginia | 22908 | Recruiting |
| Washington Gastroenterology - Tacoma ( Site 0295) | Tacoma | Washington | 98405 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06651281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 25, 2025 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06651281 live on ClinicalTrials.gov.